Apply to trial NCT07099443

A few quick questions so the study team can decide if you might be a fit.

RecruitingClinical trial

Determinants of the Response to BTK Degraders (BTKd) in Chronic Lymphocytic Leukemia

The aim of the REBELLE cohort - bio-collection is to collect samples from patients with Chronic Lymphocytic Leukemia candidates or those exposed to BTK degraders to evaluate the mechanisms of resistance to these new molecules. To do this, an additional blood or bone marrow sample to those planned in the context of patient care or a residual lymph node biopsy sample will be collected after signing consent.

How this works

Answer a few questions
About 5 to 10 minutes. Skip-friendly where possible.
We connect you with the study team
When a site picks up your application, we introduce you to their team directly — with you on the thread.
The team reaches out to schedule screening
Usually within a few business days, via the contact you give.

EmailWe save your progress under this email and copy you when we connect you with the study team.

I agree that Hipa.ai may share my application — my name, contact details, and my answers, including health information — with the official study team for this trial so they can review my responses and contact me.

By continuing, you agree to our terms of service.

Determinants of the Response to BTK Degraders (BTKd) in Chronic Lymphocytic Leukemia

How this works

Answer a few questions

We connect you with the study team

The team reaches out to schedule screening